We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$55.1B
1-Year Est. Return
24.23%
This Fund
S&P 500
This Quarter
Est. Return
+8.62%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
–
AUM
$22.7B
AUM Growth
-$33.5M
(-0.15%)
Cap. Flow
-$2B
Cap. Flow
% of AUM
-8.79%
Top 10 Holdings %
Top 10 Hldgs %
17.42%
Holding
2,101
New
297
Increased
583
Reduced
883
Closed
273
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$163M |
| 2 |
Merck
MRK
|
+$125M |
| 3 |
Royal Bank of Canada
RY
|
+$91.6M |
| 4 |
Johnson & Johnson
JNJ
|
+$89.1M |
| 5 |
Bank of Montreal
BMO
|
+$88.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$126M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$104M |
| 3 |
Johnson Controls International
JCI
|
+$91.5M |
| 4 |
Oracle
ORCL
|
+$90M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$88.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.94% |
| 2 | Consumer Discretionary | 13.96% |
| 3 | Healthcare | 13.37% |
| 4 | Financials | 11.87% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Royalty Pharma
RPRX
$26.1B
| $1.06M | ﹤0.01% |
+24,232
| New | +$1.15M |
|
1227
MillerKnoll
MLKN
$1.5B
| $1.05M | ﹤0.01% |
25,600
+1,037
| +4% | +$39.7K |
|
1228
InterDigital
IDCC
$6.68B
| $1.04M | ﹤0.01% |
16,424
-5,127
| -24% | -$335K |
|
1229
Bentley Systems
BSY
$9.54B
| $1.04M | ﹤0.01% |
+22,163
| New | +$1.01M |
|
1230
Essential Utilities
WTRG
$11.2B
| $1.04M | ﹤0.01% |
23,211
-78,257
| -77% | -$3.53M |
|
1231
Arcus Biosciences
RCUS
$3.57B
| $1.02M | ﹤0.01% |
36,476
+21,488
| +143% | +$748K |
|
1232
Moderna
MRNA
$21.5B
| $1.02M | ﹤0.01% |
7,784
-23,225
| -75% | -$3.37M |
|
1233
Invesco QQQ Trust
QQQ
$455B
| $1.02M | ﹤0.01% |
+3,195
| New | +$1.02M |
|
|
TSC
1234
DELISTED
TriState Capital Holdings, Inc.
TSC
| $1.01M | ﹤0.01% |
44,028
-135,805
| -76% | -$3.02M |
|
1235
Cerence
CRNC
$382M
| $1.01M | ﹤0.01% |
+11,292
| New | +$1.24M |
|
1236
Huntsman Corp
HUN
$2.24B
| $1.01M | ﹤0.01% |
35,098
-23,549
| -40% | -$659K |
|
1237
Oppenheimer Holdings
OPY
$1.17B
| $1.01M | ﹤0.01% |
25,256
-100,144
| -80% | -$3.71M |
|
1238
Brady Corp
BRC
$4.45B
| $1.01M | ﹤0.01% |
18,887
-27,182
| -59% | -$1.42M |
|
1239
SelectQuote
SLQT
$114M
| $1.01M | ﹤0.01% |
+34,112
| New | +$894K |
|
|
AGNT
1240
AGNT Inc
AGNT
$664M
| $1M | ﹤0.01% |
21,982
-15,580
| -41% | -$830K |
|
1241
Phreesia
PHR
$632M
| $1M | ﹤0.01% |
19,174
+15,074
| +368% | +$950K |
|
1242
Allegro MicroSystems
ALGM
$8.58B
| $990K | ﹤0.01% |
39,026
+15,587
| +67% | +$446K |
|
1243
The Ensign Group
ENSG
$10.1B
| $982K | ﹤0.01% |
10,467
-36,577
| -78% | -$3.13M |
|
1244
Unity
U
$12.5B
| $982K | ﹤0.01% |
9,784
-4,529
| -32% | -$558K |
|
1245
ACI Worldwide
ACIW
$5.72B
| $971K | ﹤0.01% |
25,534
+328
| +1% | +$12.9K |
|
1246
Array Technologies
ARRY
$818M
| $962K | ﹤0.01% |
32,253
+7,370
| +30% | +$294K |
|
1247
BWX Technologies
BWXT
$16B
| $960K | ﹤0.01% |
14,556
-85,097
| -85% | -$5.1M |
|
1248
Cartesian Therapeutics
RNAC
$232M
| $960K | ﹤0.01% |
7,072
-2,444
| -26% | -$303K |
|
1249
Tetra Tech
TTEK
$8.23B
| $956K | ﹤0.01% |
35,220
-2,790
| -7% | -$73.9K |
|
|
ALBO
1250
DELISTED
Albireo Pharma Inc
ALBO
| $954K | ﹤0.01% |
27,063
+35
| +0.1% | +$1.29K |
|
Similar funds
Man Group's Q1 2021 Portfolio in Review
As of Q1 2021, Man Group held 2,101 positions worth $22.7B, down 0.15% from $22.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Man Group withdrew a net $2B in Q1 2021, closing 273 positions and reducing 883 holdings. Its most notable exit was IHS Markit Ltd. Common Shares, an estimated $49.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Man Group opened a new position in iShares Russell 2000 Value ETF worth $45.3M.
- Man Group's largest Q1 2021 buy was iShares Russell 2000 Value ETF: 283,817 shares worth $45.3M.
- Man Group added most to Intel in Q1 2021, an estimated $163M increase.
- Man Group's biggest Q1 2021 reduction was Alexion Pharmaceuticals, cutting an estimated $126M.
- Man Group fully exited IHS Markit Ltd. Common Shares in Q1 2021, selling an estimated $49.1M.
- Man Group's ten largest holdings make up 17% of its $22.7B portfolio in Q1 2021.
- Man Group opened 297 new positions and closed 273 in Q1 2021.
- Man Group's portfolio value fell 0.15% quarter-over-quarter to $22.7B.
Based on Man Group's 13F filing for Q1 2021, filed 17 May 2021.